87 lines
4.8 KiB
Markdown
87 lines
4.8 KiB
Markdown
# Phase 4AB — calyx contact-scope counterfactuals
|
||
|
||
This is an exploratory mechanism diagnostic, NOT an APL physiological model,
|
||
learning experiment, parameter calibration or new formal runtime candidate.
|
||
All previous scientific artifacts remain read-only. Only new output directories
|
||
are permitted. No additional download is required.
|
||
|
||
## Question and predeclared controls
|
||
|
||
Does removal of anatomically labelled calyx PN→KC input alter persistent KC
|
||
activity without also removing the same PNs' antennal-lobe output?
|
||
|
||
Select PN/ROI pairs from actual Phase 4AA APL→ALPN synaptic contacts whose
|
||
`primary_post` is exactly `CA(L)` or `CA(R)`. Select PN→KC contacts only when
|
||
their source PN and actual `primary_post` match that pair. This is **ROI-level
|
||
co-location**, not proof of the same bouton, receptor, physiological coefficient,
|
||
or even a per-presynaptic-site ROI annotation. `primary_post` labels the
|
||
postsynaptic site. Never reclassify `CentralBrain-unspecified` by proximity.
|
||
|
||
Compare four conditions on the same eligible PN set:
|
||
|
||
1. Frozen reference; no changed weights or injected current.
|
||
2. Block only the matched CA PN→KC contact component.
|
||
3. Block all PN→KC output of those PNs, irrespective of ROI.
|
||
4. Block all fast outgoing synaptic weights of those PNs (broad scope control).
|
||
|
||
These are complete-block engineering interventions, not estimates of biological
|
||
APL inhibition. There is no strength sweep or winner selection. Condition 4
|
||
does **not** silence PN somata or alter their force requests. The frozen graded
|
||
APL input matrix remains active in all four conditions; condition 4 is therefore
|
||
not a complete PN knockout. All fast edge slots remain present. Output masks are
|
||
not plastic masks, and nothing is written back to base CSR or an old model.
|
||
|
||
For condition 2, the in-memory diagnostic effective weight is
|
||
`float32(float64(frozen_effective_weight) * (raw_count - CA_count) / raw_count)`.
|
||
The linear per-contact decomposition is an engineering consequence of the
|
||
existing linear weight model, not a measured transmitter-release law.
|
||
At strength zero there is no arithmetic or write at all; identity must be exact.
|
||
Conditions 3/4 set only the declared fast effective weights to zero. Anatomical
|
||
counts, transmitter signs, LIF/refractory/delay, APL matrices and calibration,
|
||
eligibility-v2 and the 14,232 plastic-edge mask remain frozen.
|
||
|
||
## Trials and measurements, declared before results
|
||
|
||
Use all six old calibration odors, seed 131101, the frozen Phase 4V DoOR→PN
|
||
request generator, 120 ms stimulus followed by observation to 1,000 ms. Do not
|
||
consume held-out odors. Reset all states between trials. Repeat every condition
|
||
for odor 0 to test exact determinism. No DAN reinforcement or weight training.
|
||
|
||
Record all spike events, all final counts/V/g, watched PN/KC/ALLN states, original
|
||
force requests and their accepted/preexisting/blocked status, KC active fraction,
|
||
late KC82312/VA6/ALLN activity (500–1,000 ms), and class-wise counts. All conditions
|
||
share requested inputs; delivered events need not match because recurrent state
|
||
and refractory periods can change. Explicitly report this distinction.
|
||
|
||
Unmodified trials must reproduce Phase 4Z whole events, watched states and
|
||
Phase 4Y final arrays bit-for-bit. Each first-odor repeat must be exact. Run the
|
||
five frozen Phase 4C trials against the deterministic-v2 archived oracle in new
|
||
output paths. Original v1 files remain preserved, not relabelled as deterministic.
|
||
|
||
Additionally, replay the first frozen trial with its recorded events fixed, using
|
||
the frozen ordered reduction and 18-step queue to validate locality: no terminal
|
||
mask affects non-KC arrivals; broad controls may do so. This fixed-event test
|
||
only measures the direct operator, not whole-brain causality.
|
||
|
||
## Interpretation gate
|
||
|
||
Reduced KC activity alone is not repaired encoding or memory. A broad blockade
|
||
can destroy useful drive. If CA blockade fails to remove the late KC response,
|
||
report that it is insufficient under this model; do not increase gain or relabel
|
||
unknown contacts. If it succeeds while ALPN/ALLN persist, report scope-specific
|
||
model counterfactual evidence, not proof that biological APL has that strength.
|
||
No result in this phase can generate a learned/physiological candidate.
|
||
|
||
## Source boundaries
|
||
|
||
- MaleCNS official v1.0 syn-partners, CC BY 4.0, already verified in Phase 4AA:
|
||
https://male-cns.janelia.org/download/
|
||
- Prisco et al. (2021), doi:10.7554/eLife.74172: local calyx APL interactions;
|
||
does not assign MaleCNS edge-specific inhibition coefficients.
|
||
- Amin et al. (2020), doi:10.7554/eLife.56954: spatially localized APL activity
|
||
and inhibition; does not validate the present engineering complete-block rule.
|
||
|
||
Unknown: bouton identity, receptor distribution, strength/time course of terminal
|
||
release modulation, and whether adding such physiology would rescue memory.
|
||
No game, decoder, RL, visual input, threshold/eta tuning, or next-phase training.
|